Elizaveta V. Mordvinova

Elizaveta V. Mordvinova

Auto-generated profile, based on publicly available information

Elizaveta V. Mordvinova

Samara State Medical University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Russian Open Medical Journal
Verified
Journal Article
Closed access
IDIgor L. Davydkin
Igor L. Davydkin
TKTatyana P. Kuzmina
Tatyana P. Kuzmina
KNKsenia V. Naumova
Ksenia V. Naumova
RKRais K. Khayretdinov
Rais K. Khayretdinov
ODOlesya E. Danilova
Olesya E. Danilova
EMElizaveta V. Mordvinova
Elizaveta V. Mordvinova
The article is dedicated to contemporary views on the change of endothelial function in the patients with lymphoproliferative disorders prior to, and in the process of, chemotherapeutic treatment. Considering that possibilities of standard examination do not always help identifying subclinical endothelial dysfunction, it is necessary to use specific methods, in particular, to determine the levels of endothelin-1 and vascular endothelial growth factor to monitor endothelial function. The objective of this review is to identify problems and prospects for recognizing early subclinical changes of endothelial function in the patients with lymphoproliferative disorders before and after chemotherapy. Assessing presence and severity of endothelial dysfunction may be useful for determining subclinical stages of cardiovascular damage, stratifying the risk of the patients with confirmed cardiovascular disease, and reducing the likelihood of cardio- and endotheliotoxic effects in patients long after chemotherapy. That is why early detection and immediate therapy of cardiovascular toxicity is currently the most important task in the patients with lymphoproliferative disorders, receiving chemotherapy.

1 January 2014 in Systemic Hypertension
Verified
Journal Article
Open access
EME.V. Mordvinova
E.V. Mordvinova
EOE.V. Oschepkova
E.V. Oschepkova
AFAndrey Fedorovich
Andrey Fedorovich
ARA.N. Rogoza
A.N. Rogoza
Aim: to evaluate the main parameters of the microcirculatory blood flow and to determine its reserve capacity in patients with arterial hypertension (AH) and different degrees of cardiovascular risk (CVR). Subjects and methods. We examined 64 subjects aged 47–58 years, of which 27 were healthy volunteers and 37 patients with 1st and 2nd degree arterial hypertension, with medium, high and very high CVR (the antihypertensive therapy was cancelled for 2 weeks before the study). In all subjects laser Doppler flowmetry (LDF) with studing initial perfusion parameters, 2 constrictor and 3 dilatator tests waку perfomed. To assess the status of the tone-shaping «active» and «passive» parts of microcirculatory modulation, analysis of the amplitude and frequency spectrum of LDF-grams was carried out. Results. A significant increase in the rate of «base perfusion» in all hypertensive groups compared with the control group was found. The amplitude of respiratory oscillations was one-third higher in high and very high CVR groups in comparison with the control, the amplitude of the myogenic and neurogenic oscillations were maximal and reached significant values in very high CVR group. A reduction in constrictor response in hypertensive patients with middle and high CVR and its increase in the very high CVR group was shown during constrictor functional tests. The power of perfusion increase was reduced in response to all kinds of dilatator stimulus in hypertensive patients group. Conclusion. The findings indicate a progressive increase in the level of «base perfusion», worsening of venous congestion symptoms in hypertensive patients with the progression in CVR severity. High and very high CVR patients showed a reduction in myogenic tone of microvessels when compared with those with normotension. Dilatator functional tests showed a tendency to lower capillary blood flow reserve in hypertensive patients compared with the control group. Key words: arterial hypertension, laser doppler flowmetry, constrictor and dilatator functional tests, cardio-vascular risk

26 December 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
IDI. L. Davydkin
I. L. Davydkin
EME. V. Mordvinova
E. V. Mordvinova
ТКТ. П. Кузьмина
Т. П. Кузьмина
KNK. V. Naumova
K. V. Naumova
EFE. S. Fatenkova
E. S. Fatenkova
The article is devoted to the modern understanding of endothelial dysfunction development, the role of hyperhomocysteinemia, and, as a consequence, hypertension in patients with multiple myeloma receiving multiagent chemotherapy. Considering that the potential of a standard examination does not allow identifying subclinical endothelial dysfunction, using specific techniques is necessary, in particular, to determine the homocysteine level to monitor the endothelial function.The aim of this review was to summarize the current understanding of hypertension etiology and prospects for detecting early, subclinical endothelial changes, including in patients with multiple myeloma.Assessment of endothelial dysfunction can be useful for detecting precisely the subclinical cardiovascular disease in order to stratify the risk of developing cardiovascular events in patients receiving multiagent chemotherapy.